Clinical trial

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

NCT03216343

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Chiauranib Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-11-09

PhasePHASE1

Conditions

Small Cell Lung Cancerverified · MONDO: small cell lung carcinoma

Interventions

ChiauranibDRUG

Sponsors & collaborators

Chipscreen Biosciences, Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03216343 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.